Clinical trial
Intranasal Ketamine With Dexmedetomidine for the Treatment of Children With Autism Spectrum Disorder
NCT03434366 is registered in ClinicalTrials.gov with Guangzhou Women and Children's Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intranasal Ketamine With Dexmedetomidine for the Treatment of Children With Autism Spectrum Disorder
- Lead sponsor
- Guangzhou Women and Children's Medical Center
- Phase
- Phase 2
- Overall status
- Suspended
- Start date
- January 20, 2018
- Completion date
- December 30, 2023
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.